Analysis of the efficacy and survival of allogeneic hematopoietic stem cell transplantation and nontransplantation treatment in chronic active Epstein-Barr virus infection.

Cell Transplant · 2026 · PMC13222441 · PMID 42216799

Europe PMC DOI

hedged sentences

0.4370

closest p · 8.7× alpha

0.4370

boldest claim

The sentences

did not reach statistical significanceP = 0.437not close (p > 0.1)

The 3-year EFS was 58.3% in the PD-1 group and 87.5% in the HSCT group; numerically higher EFS with allo-HSCT did not reach statistical significance ( P = 0.437; Fig. 3f ).

also in 111,027 other papers

a nonsignificant trendno p-value reported

Pediatric (<18 years) and adult (≥18 years) patients showed no significant differences in baseline characteristics; a nonsignificant trend toward lower HLH incidence was observed in pediatric patients ( Supplementary Table 3 ).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.